Suppr超能文献

含甲氧基肟取代基的偶极离子头孢菌素的外膜通透性和β-内酰胺酶稳定性

Outer membrane permeability and beta-lactamase stability of dipolar ionic cephalosporins containing methoxyimino substituents.

作者信息

Nikaido H, Liu W, Rosenberg E Y

机构信息

Department of Molecular and Cell Biology, University of California, Berkeley 94720.

出版信息

Antimicrob Agents Chemother. 1990 Feb;34(2):337-42. doi: 10.1128/AAC.34.2.337.

Abstract

Some enteric bacteria, such as Enterobacter cloacae, can develop high-level resistance to broad-spectrum cephalosporins by overproducing their chromosomally encoded type I beta-lactamases. This is because these agents are hydrolyzed rapidly at pharmacologically relevant, low (0.1 to 1 microM), concentrations, owing to their high affinity for type I enzymes. In contrast, the more recently developed cephalosporins, with quaternary-nitrogen-containing substituents at the 3 position, show increased efficacy against beta-lactamase-overproducing strains and, indeed, have a much lower affinity for type I enzymes. However, the possible contribution of an improved outer membrane permeability in their increased efficacy has not been studied. We found by proteoliposome swelling assays that cefepime, cefpirome, and E-1040 all penetrated the porin channels of Escherichia coli and E. cloacae much more rapidly than did ceftazidime and at least as rapidly as did cefotaxime. Considering that the influx of anionic compounds such as cefotaxime and ceftazidime will be further retarded in intact cells, owing to the Donnan potential, we expect that the newer compounds will penetrate intact cells 2 to 10 times more rapidly than will cefotaxime and ceftazidime. The kinetic parameters of hydrolysis of these agents by E. cloacae beta-lactamase showed that at 0.1 microM, they were hydrolyzed much more slowly than was cefotaxime and at about the same rate as or a lower rate than was ceftazidime. The combination of these two effects explains nearly quantitatively why these newer agents are more effective against some of the beta-lactamase-overproducing gram-negative bacteria.

摘要

一些肠道细菌,如阴沟肠杆菌,可通过过量产生其染色体编码的I型β-内酰胺酶而对广谱头孢菌素产生高水平耐药性。这是因为这些药物在药理学相关的低浓度(0.1至1 microM)下会迅速被水解,这是由于它们对I型酶具有高亲和力。相比之下,最近开发的在3位带有含季氮取代基的头孢菌素,对β-内酰胺酶过量产生的菌株显示出更高的疗效,并且实际上对I型酶的亲和力要低得多。然而,其外膜通透性改善在提高疗效方面的可能作用尚未得到研究。我们通过蛋白脂质体肿胀试验发现,头孢吡肟、头孢匹罗和E-1040穿透大肠杆菌和阴沟肠杆菌孔蛋白通道的速度比头孢他啶快得多,且至少与头孢噻肟一样快。考虑到由于唐南电位,完整细胞中头孢噻肟和头孢他啶等阴离子化合物的流入会进一步受阻,我们预计新化合物穿透完整细胞的速度将比头孢噻肟和头孢他啶快2至10倍。阴沟肠杆菌β-内酰胺酶对这些药物水解的动力学参数表明,在0.1 microM时,它们的水解速度比头孢噻肟慢得多,且与头孢他啶的水解速度大致相同或更低。这两种作用的结合几乎定量地解释了为什么这些新药物对一些β-内酰胺酶过量产生的革兰氏阴性菌更有效。

相似文献

3
Affinity of cephalosporins for beta-lactamases as a factor in antibacterial efficacy.
Antimicrob Agents Chemother. 1986 May;29(5):845-8. doi: 10.1128/AAC.29.5.845.
4
Mechanism of inhibition of chromosomal beta-lactamases by third-generation cephalosporins.
Rev Infect Dis. 1988 Jul-Aug;10(4):752-60. doi: 10.1093/clinids/10.4.752.
5
Activity of cefepime against ceftazidime-resistant gram-negative bacilli using low and high inocula.
J Antimicrob Chemother. 1995 Jun;35(6):765-73. doi: 10.1093/jac/35.6.765.
7
Cephalosporinase interactions and antimicrobial activity of BMY-28142, ceftazidime and cefotaxime.
J Antibiot (Tokyo). 1988 Jan;41(1):86-93. doi: 10.7164/antibiotics.41.86.
8
In vitro antibacterial activity of FK037, a novel parenteral broad-spectrum cephalosporin.
J Antibiot (Tokyo). 1993 Jan;46(1):71-87. doi: 10.7164/antibiotics.46.71.
9
The activity of BMY 28142 a new broad spectrum beta-lactamase stable cephalosporin.
J Antimicrob Chemother. 1986 Apr;17(4):441-52. doi: 10.1093/jac/17.4.441.

引用本文的文献

1
A review on current advancement in zebrafish models to study chronic inflammatory diseases and their therapeutic targets.
Heliyon. 2024 May 23;10(11):e31862. doi: 10.1016/j.heliyon.2024.e31862. eCollection 2024 Jun 15.
2
Cephalosporin resistance, tolerance, and approaches to improve their activities.
J Antibiot (Tokyo). 2024 Mar;77(3):135-146. doi: 10.1038/s41429-023-00687-y. Epub 2023 Dec 19.
3
Class C β-Lactamases: Molecular Characteristics.
Clin Microbiol Rev. 2022 Sep 21;35(3):e0015021. doi: 10.1128/cmr.00150-21. Epub 2022 Apr 18.
5
Potential Antibiotics for the Treatment of Neonatal Sepsis Caused by Multidrug-Resistant Bacteria.
Paediatr Drugs. 2021 Sep;23(5):465-484. doi: 10.1007/s40272-021-00465-z. Epub 2021 Aug 26.
9
Emerging Strategies to Combat β-Lactamase Producing ESKAPE Pathogens.
Int J Mol Sci. 2020 Nov 12;21(22):8527. doi: 10.3390/ijms21228527.

本文引用的文献

1
Cefoxitin resistance by a chromosomal cephalosporinase in Escherichia coli.
J Antibiot (Tokyo). 1980 Sep;33(9):1037-42. doi: 10.7164/antibiotics.33.1037.
2
Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes.
J Bacteriol. 1982 Nov;152(2):636-42. doi: 10.1128/jb.152.2.636-642.1982.
4
Purification and properties of a binding protein for branched-chain amino acids in Pseudomonas aeruginosa.
J Bacteriol. 1980 Mar;141(3):1055-63. doi: 10.1128/jb.141.3.1055-1063.1980.
5
Novel resistance selected by the new expanded-spectrum cephalosporins: a concern.
J Infect Dis. 1983 Mar;147(3):585-9. doi: 10.1093/infdis/147.3.585.
6
Characterization of beta-lactamase induction in Enterobacter cloacae.
Antimicrob Agents Chemother. 1983 Jan;23(1):91-7. doi: 10.1128/AAC.23.1.91.
7
9
Porin channels in Escherichia coli: studies with beta-lactams in intact cells.
J Bacteriol. 1983 Jan;153(1):232-40. doi: 10.1128/jb.153.1.232-240.1983.
10
Do beta-lactamases 'trap' cephalosporins?
J Antimicrob Chemother. 1985 May;15(5):511-4. doi: 10.1093/jac/15.5.511.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验